Sailash Patel serves as Executive at Furiex Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Sailash Patel has executed 6 insider transactions totaling $3.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 2, 2014 involved selling 26,444 shares valued at $0.
Sailash Patel currently holds 26,444 shares of Furiex Pharmaceuticals, Inc. (FURX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sailash Patel has been a net seller of FURX stock. They have purchased $0 and sold $3.6M worth of shares.
Sailash Patel's most recent insider trade was on Jul 2, 2014, when they sold 26,444 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $104.00 |
| Discretionary |
| Jun 24, 2014 | FURX | $300.0K | Option Exercise | 32,928 | $9.11 | Discretionary |
| Jun 10, 2014 | FURX | $157.4K | Sale | 1,504 | $104.68 | Discretionary |
| Feb 28, 2014 | FURX | $0 | Award | 12,000 | $N/A | Discretionary |
| Nov 15, 2013 | FURX | $0 | Award | 1,000 | $N/A | Discretionary |